革新的がん研究支援室

AMED news

AMED news - Detail

2019.01.16
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
A press release from the Japan Agency for Medical Research and Development (AMED):

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

Visit AMED website